PRIMAQUINE PHOSPHATE

Primaquine phosphate has equivalent antimalarial activity and is used in similar indications for radical cure and transmission blocking. Side effects include abdominal pain, nausea, hemolysis in G6PD deficiency, cyanosis, and headache, necessitating careful dosing and monitoring in atrisk populations. Only GMP materials will be supplied, logistics all according to GDP.

SKU: eec1f3a62add Category: Tag:

Product Description


Mechanism of Action

PRIMAQUINE PHOSPHATE exhibits a complex, multipathway biochemical activity profile influencing enzymatic cascades, receptormediated signalling networks, mitochondrial respiration, oxidativestress balance, intracellular ion regulation, membranepotential stability and transcriptionfactor activation. Its structural framework suggests potential interactions with catalytic residues, allosteric regulatory pockets, membraneembedded receptor complexes and intracellular signalling scaffolds. These interactions may modulate phosphorylation patterns, secondmessenger systems (Ca²⁺, IP, DAG, cAMP), ATP turnover, ROS equilibrium, cytoskeletal organisation and organelle stressresponse thresholds.

Depending on dosing, PRIMAQUINE PHOSPHATE can influence metabolic flux routing, alter chromatin accessibility, modify vesicular transport, reshape mitochondrial output and regulate transcriptional clusters associated with cellular survival, apoptosis, autophagy, inflammatory signalling and metabolic adaptation. This multiaxis behaviour supports its wide applicability in advanced biochemical and pharmacodynamic research systems.

Benefits and Advantages

The compound is widely utilised for:

  • Receptorligand interaction analysis and affinity modelling
  • Enzymekinetic profiling and catalyticpathway reconstruction
  • Mitochondrialbioenergetics assays and oxidativestress evaluation
  • Multiomics integration (transcriptomics, proteomics, metabolomics, phosphoproteomics)
  • Cytoskeletal and membranedynamics studies
  • Apoptosis, necroptosis, autophagy and ferroptosis pathway characterisation
  • SAR (structureactivity relationship) development and molecular screening
  • Pharmacodynamic modelling and mechanistic doseresponse simulations

Side Effects and Risks

Potential laboratoryobserved risks include:

  • Excessive ROS production and oxidative imbalance
  • Mitochondrial hyperactivation or suppression of electrontransport complexes
  • Ionchannel dysregulation (Na⁺, K⁺, Ca²⁺)
  • Unintended receptor crosstalk or inhibition
  • Cytoskeletal destabilisation and membrane-integrity compromise
  • Dosedependent cytotoxicity or activation of apoptotic/autophagic pathways
  • Transcriptional or epigenetic instability
  • Upregulation of inflammatory cascades (NF-κB, JNK, p38 MAPK)

Use exclusively within controlled laboratory conditions and according to strict biosafety standards.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C15H24N3O5P1

Molecular Weight

455.34 g/mol

CAS Number

63-45-6

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

5.64e-02 g/L

Purity

Purity information is available upon request (COA).

Synonym

primaquine diphosphate; 63-45-6; PRIMAQUINE PHOSPHATE; Malquine; 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2)

IUPAC/Chemical Name

4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid

InChl Key

GJOHLWZHWQUKAU-UHFFFAOYSA-N

InChl Code

InChI=1S/C15H21N3O.2H3O4P/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14;2*1-5(2,3)4/h4,6,8-11,18H,3,5,7,16H2,1-2H3;2*(H3,1,2,3,4)

References

https://pubchem.ncbi.nlm.nih.gov/compound/6135;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download